Gabapentin

Product manufactured by Cardinal Health

Application Nr Approved Date Route Status External Links
ANDA076017 2005-04-29 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Epilepsy Gabapentin Is Indicated As Adjunctive Therapy In The Treatment Of Partial Seizures With And Without Secondary Generalization In Patients Over 12 Years Of Age With Epilepsy. Gabapentin Is Also Indicated As Adjunctive Therapy In The Treatment Of Partial Seizures In Pediatric Patients Age 3 - 12 Years.

All Formulated Excipients (4 Total)

Name Structure Kind Function Status
1. Ferrosoferric Oxide FERROSOFERRIC OXIDE Molecular
2. Starch, Corn STARCH, CORN Unresolved
3. Gelatin GELATIN Unresolved
4. Lactose Monohydrate LACTOSE MONOHYDRATE Molecular

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Gabapentin GABAPENTIN ZINC1554010

Comments